10 Best Performing American Stocks in June 2026
Fidelity says “Market breadth has broadly remained strong” and “unrelenting corporate earnings growth has underpinned stocks.” That suggests some recent rallies are happening in a market still...
Sellas Life Sciences Group Inc. (SLS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 4,368,200 | $18,477,486 | +131% | 0% | |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 2,037,162 | $8,617,196 | +52% | 0.01% |
| 3. | 626,000 | $2,647,980 | 0% | ||
| 4. | 449,800 | $1,902,654 | +366% | 0% | |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 403,165 | $1,705,388 | +427% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.59 | 63,400 | $100,806.00 | 104,400 | 2025-11-19 | Filing | |
| $1.48 | 10,000 | $14,800.00 | 20,400 | 2025-06-12 | Filing | |
| $1.69 | 20,000 | $33,800.00 | 30,400 | 2025-05-30 | Filing | |
| $1.80 | 20,000 | $36,000.00 | 41,000 | 2025-05-22 | Filing | |
| $4.94 | 20,000 | $98,742.00 | 23,500 | 2014-02-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.61 | 6,494 | $16,938.30 | 161,689 | 2022-12-05 | Filing | |
| $2.59 | 1,159 | $3,001.81 | 29,347 | 2022-12-05 | Filing | |
| $2.59 | 2,153 | $5,576.27 | 56,344 | 2022-12-05 | Filing | |
| $6.25 | 2,120 | $13,251.91 | 121,167 | 2021-12-02 | Filing | |
| $6.25 | 847 | $5,297.73 | 42,028 | 2021-12-02 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,232,433 | $18,190,706 | 3.36% | |
| 2. | 288,018 | $4,251,146 | 0.27% | |
| 3. | 23,327 | $344,307 | 0.18% | |
| 4. | 10,000 | $147,600 | 0.01% | |
| 5. | 690 | $10,184 | 0% |
News See All
10 Stocks Investors Are Chasing Right Now
Ten stocks kicked off the shortened trading week with strong double-digit gains, mirroring a rally in the broader market buoyed by the US and Iran’s decision to end hostilities.
Is SELLAS Life Sciences Group, Inc. (SLS) A Good Stock To Buy Now?
Is SLS a good stock to buy? We came across a bullish thesis on SELLAS Life Sciences Group, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on SLS.
9 Stocks Winning by Double Digits
Nine stocks clocked strong double-digit gains on Thursday, bucking a lackluster performance in the broader market, thanks to stellar earnings performance and acquisition news that sparked buying appetite...
10 Stocks That Will 10X According to Social Media
What started as a pandemic lockdown pastime has become a force Wall Street can't ignore.
18 Stocks on Jim Cramer’s Radar: Strategy, GE Aerospace, and Best Buy
In this article, we will look at the stocks on Jim Cramer’s radar on Mad Money, as he explained that many investors might be missing out on the market’s biggest winners.
9 Best Healthcare Penny Stocks to Buy According to Hedge Funds
Volatility in the equity market has been on another level in the first quarter of the year.
10 Popular Penny Stocks on Robinhood to Buy
Robinhood is a FINRA and SEC-regulated broker. It plays the role of a bridge that routes customer orders to market makers and exchanges.
Sellas Life Sciences Group Inc. (SLS) Advances Cancer Pipeline with $31M Funding and Upcoming R&D Showcase
Sellas Life Sciences Group Inc. (NASDAQ:SLS) is one of the top long-term biotechnology stocks to buy.
Top 8 Long-Term Biotechnology Stocks to Buy
Momentum in biotechnology stocks is accelerating after years of underperformance.
Hedge Fund Resource Center